MedTechDive

Bill Shields, who led transcatheter mitral and tricuspid therapies at Medtronic, has joined Versa Vascular, developer of a valve repair treatment.

The multiyear partnership will connect Abbott's over-the-counter Lingo sensor and the Google Health app.

Philips framed the revised agreement with Exor, the holding company of Italy's billionaire Agnelli family, as evidence of confidence in its strategy.

Medical device companies are getting millions of dollars back from Trump's overturned tariffs. Now they're bracing for what comes next.

Shifting more responsibility for procedure costs to hospitals is unlikely to pressure prices for orthopedic implants, CEOs said.

Buying Varex will increase Teledyne's exposure to the healthcare market. Teledyne said the companies' imaging technologies complement each other with minimal overlap.

The proposed "RAPID" pathway could help some new medical devices get national Medicare coverage within months of FDA authorization.

The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world evidence.

Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm's existing devices.

NYU Langone Health and Dana-Farber Cancer Institute built an oncology decision support tool to guide clinicians through treatment. Now, the institutions are commercializing the product so other health systems can use it too.